French Observatory of Familial Hypercholesterolemia in Cardiology (FH Care)
The Family Hypercholesterolemia remains poorly diagnosed disease with an outlet sometimes suboptimal care. However, the Family Hypercholesterolemia exposes patients concerned at increased cardiovascular risk.
The frequency of familial hypercholesterolemia in cardiologic is little studied and remains unknown, and there is little data on the profile of patients, diagnostic methods and management.
- Establish a monitoring patients with hypercholesterolemia Family cardiology in France
- Characterize the Family hypercholesterolemia in cardiology, including assessing the frequency of the most severe forms, which are at higher cardiovascular risk.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||French Observatory of Familial Hypercholesterolemia in Cardiology|
- Frequency of the Family Hypercholesterolemia in cardiology [ Time Frame: 1 day ] [ Designated as safety issue: No ]Number of Family Hypercholesterolemia among patients with LDL-C> 1.9g / l without hypoglycemic treatment or> 1.6g / l in lipid-lowering therapy
|Study Start Date:||October 2014|
|Estimated Study Completion Date:||December 2023|
|Estimated Primary Completion Date:||December 2022 (Final data collection date for primary outcome measure)|
|Family Hypercholesterolemia in cardiology|
Please refer to this study by its ClinicalTrials.gov identifier: NCT02013713
|Contact: Albert HAGEGE||33(1) 43 22 33 firstname.lastname@example.org|
|Contact: Geneviève MULAK||33(1) 44 90 70 email@example.com|
|European Hospital Georges Pompidou||Not yet recruiting|
|Paris, France, 75015|
|Contact: Albert Hagège|
|Contact: Geneviève Mulak +33 (0)1 44 90 70 28 firstname.lastname@example.org|
|Principal Investigator: Albert Hagège|